US Pharma MarketingBMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
BMS is the latest large pharma company to make a major bet on AI, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared intelligence platform” across the drugmaker’s global operations.
Source: FierceBiotech